PPIPT00599
Target Protein Information
| Protein_Name | T cell receptor alpha chain constant |
|---|---|
| Protein_Sequence | IQNPDPAVYQLRDSKSSDKSVCLFTDFDSQTNVSQSKDSDVYITDKTVLDMRSMDFKSNSAVAWSNKSDFACANAFNNSIIPEDTFFPSPESSCDVKLVEKSFETDTNLNFQNLSVIGFRILLLKVAGFNLLMTLRLWSS |
| Organism_Source | Homo sapiens |
| Functional_Classification | T-cell receptor constant region |
| Cellular_Localization | Plasma membrane |
| Gene_Names | TRAC |
| UniProt_ID | P01848 |
| Protein-Protein Interaction Networks | |
Peptide Basic Information
| Peptide_Name | Pep8 |
|---|---|
| Peptide_Sequence | WNASWSNKSLEQIWNHT |
| Peptide_Length | 17 |
| Peptide_SMILES | CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)O)[C@@H](C)O |
| Chemical_Modification | None |
| Cyclization_Method | None |
| Linear/Cyclic | Cyclic |
| N-terminal_Modification | Free |
| C-terminal_Modification | Amide |
| Amino_Acid_Distribution | |
|
|
|
Peptide Physicochemical
| Molecular_Weight | 2101.26 |
|---|---|
| Aliphatic_Index | 51.76471 |
| Aromaticity | 0.17647 |
| Average_Rotatable_Bonds | 3.82353 |
| Charge_at_pH_7 | 0.09037 |
| Isoelectric_point | 7.54973 |
|---|---|
| Number_of_Hydrogen_Bond_Acceptors | 29 |
| Number_of_Hydrogen_Bond_Donors | 32 |
| Topological_Polar_Surface_Area | 921.57000 |
| X_logP_energy | -9.35180 |
Interaction Information
| Affinity | IC50=15 uM |
|---|---|
| Affinity_Assay | cell proliferation assay |
| PDB_ID | None |
| Type | Inhibitor |
| Structure | |
Reference Information
| Document_Type | Patent |
|---|---|
| Title | PEPTIDES DERIVED FROM HIV GP41 FOR TREATING T-CELL MEDIATED PATHOLOGIES |
| Release_Year | 2015 |
| Patent_ID | US20150175666A1 |